MIM
MetLife Investment Management Portfolio holdings
AUM
$17B
1-Year Return
25.61%
This Quarter Return
+8.56%
1 Year Return
+25.61%
3 Year Return
+108.53%
5 Year Return
+194.13%
10 Year Return
–
AUM
$11.4B
AUM Growth
+$476M
(+4.4%)
Cap. Flow
-$297M
Cap. Flow
% of AUM
-2.6%
Top 10 Holdings %
Top 10 Hldgs %
22.33%
Holding
2,538
New
224
Increased
309
Reduced
1,136
Closed
102
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$24.7M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$21.5M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$13.5M |
| 4 |
UiPath
PATH
|
+$9.65M |
| 5 |
Targa Resources
TRGP
|
+$5.08M |
Top Sells
| 1 |
MPLX
MPLX
|
+$20.7M |
| 2 |
Apple
AAPL
|
+$16.9M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$15.6M |
| 4 |
Microsoft
MSFT
|
+$13.9M |
| 5 |
Williams Companies
WMB
|
+$9.62M |
Sector Composition
| 1 | Technology | 20.96% |
| 2 | Financials | 13.29% |
| 3 | Healthcare | 12.64% |
| 4 | Consumer Discretionary | 11.46% |
| 5 | Industrials | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2251
REV Group
REVG
$3.03B
| $170K | ﹤0.01% |
10,851
+5,180
| +91% | +$81.3K |
|
2252
International Money Express
IMXI
$429M
| $170K | ﹤0.01% |
11,455
| – | – |
|
2253
Geron
GERN
$868M
| $170K | ﹤0.01% |
120,603
+67,836
| +129% | +$95.6K |
|
2254
Ouster
OUST
$1.65B
| $170K | ﹤0.01% |
+1,360
| New | +$170K |
|
2255
Aligos Therapeutics
ALGS
$77.2M
| $169K | ﹤0.01% |
+332
| New | +$169K |
|
|
RRD
2256
DELISTED
RR Donnelley & Sons Co.
RRD
| $169K | ﹤0.01% |
+26,953
| New | +$169K |
|
2257
SFL Corp
SFL
$1.1B
| $168K | ﹤0.01% |
22,020
-14,574
| -40% | -$111K |
|
2258
Grid Dynamics Holdings
GDYN
$665M
| $168K | ﹤0.01% |
11,178
+7,629
| +215% | +$115K |
|
2259
CuriosityStream
CURI
$265M
| $168K | ﹤0.01% |
+12,309
| New | +$168K |
|
2260
AgEagle Aerial Systems
UAVS
$65M
| $167K | ﹤0.01% |
+32
| New | +$167K |
|
2261
Oric Pharmaceuticals
ORIC
$1.02B
| $167K | ﹤0.01% |
9,451
| – | – |
|
|
EVLO
2262
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $167K | ﹤0.01% |
+608
| New | +$167K |
|
2263
Babcock & Wilcox
BW
$203M
| $167K | ﹤0.01% |
+21,174
| New | +$167K |
|
|
VIRX
2264
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $167K | ﹤0.01% |
+14,707
| New | +$167K |
|
2265
FRP Holdings
FRPH
$489M
| $167K | ﹤0.01% |
5,986
| – | – |
|
2266
Alto Ingredients
ALTO
$88.2M
| $166K | ﹤0.01% |
+27,235
| New | +$166K |
|
|
IMDX
2267
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$71.3M
| $166K | ﹤0.01% |
1,448
+1,361
| +1,564% | +$156K |
|
2268
CytomX Therapeutics
CTMX
$360M
| $165K | ﹤0.01% |
26,108
+20,846
| +396% | +$132K |
|
2269
Viking Therapeutics
VKTX
$2.84B
| $165K | ﹤0.01% |
27,522
+18,376
| +201% | +$110K |
|
|
AWH
2270
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $165K | ﹤0.01% |
1,954
+798
| +69% | +$67.3K |
|
2271
Waterstone Financial
WSBF
$276M
| $164K | ﹤0.01% |
8,351
+3,044
| +57% | +$59.8K |
|
2272
GCM Grosvenor
GCMG
$682M
| $164K | ﹤0.01% |
+15,754
| New | +$164K |
|
2273
Treace Medical Concepts
TMCI
$449M
| $164K | ﹤0.01% |
+5,245
| New | +$164K |
|
2274
Evolus
EOLS
$492M
| $164K | ﹤0.01% |
+12,941
| New | +$164K |
|
2275
Titan International
TWI
$565M
| $164K | ﹤0.01% |
+19,291
| New | +$164K |
|